Leaderna Platform Spółka z Ograniczoną Odpowiedzialnością (KRS 0000848659, NIP 5833400832) is a Polish company, headquartered in Gdańsk, Pomorskie voivodeship. LEADERNA PLATFORM operates in: Scientific research and development (PKD 72.10.Z). Industry: Research and development. The company has been listed in the National Court Register since July 2, 2020. LEADERNA PLATFORM's most recently reported net revenue was 0 PLN for 2024.
No arrears identified in the analyzed sources
No arrears or bankruptcy proceedings identified in the analyzed sources.
Business profile - Leaderna Platform
Identity
- Name
- Leaderna Platform Spółka z Ograniczoną Odpowiedzialnością
- Legal form
- SPÓŁKA Z OGRANICZONĄ ODPOWIEDZIALNOŚCIĄ
- Founded
- July 2, 2020
- Registry status as of
- June 26, 2026
- Latest entry
- June 26, 2026
- Founding act
- AKT NOTARIALNY Z DNIA 28.05.2020R., ZASTĘPCA NOTARIALNY MACIEJ TOMASZEWSKI, ZASTĘPCA NOTARIUSZA KAROLA ALEKSANDROWICZA, …
Articles of association history (4)
- May 28, 2020: AKT NOTARIALNY Z DNIA 28.05.2020R., ZASTĘPCA NOTARIALNY MACIEJ TOMASZEWSKI, ZASTĘPCA NOTARIUSZA KAROLA ALEKSANDROWICZA, KANCELARIA NOTARIALNA"KAROL ALEKSANDROWICZ NOTARIUSZ" W GDAŃSKU (80-286) PRZY UL. JAŚKOWA DOLINA NR 132/16, REP. A NR 2914/2020
- September 23, 2020: 23.09.2020 ROK, REP. A NR 6592/2020, NOTARIUSZ KAROL ALEKSANDROWICZ KANCELARIA NOTARIALNA W GDAŃSKU PRZY UL. JAŚKOWA DOLINA 132/16; ZMIANA UMOWY SPÓŁKI W ZAKRESIE §7 , §8 , §12A (DODANY) TEKST JEDNOLITY
- March 13, 2023: 13.03.2023 ROK, REP. A NR 2059/2023, NOTARIUSZ KAROL ALEKSANDROWICZ KANCELARIA NOTARIALNA W GDAŃSKU PRZY UL. JAŚKOWA DOLINA 132/16; ZMIANA § 6 UST. 1 UMOWY SPÓŁKI
- June 25, 2025: 25.06.2025 ROKU; REPERTORIUM A NR 5180/2025; NOTARIUSZ KAROL ALEKSANDROWICZ; KANCELARIA NOTARIALNA W GDAŃSKU PRZY UL. JAŚKOWA DOLINA 132/16; ZMIANA § 6 UST. 1 UMOWY SPÓŁKI
Activities
Main activity
72.10.ZScientific research and development
Other activities
General codes (divisions and groups)
General codes indicate a PKD division or group without a specific subclass.
Address and contact
- Address
- UL. TARG RYBNY, 11, 2, 80-838, GDAŃSK, POLSKA
- Voivodeship
- POMORSKIE
- District
- GDAŃSK
- Not disclosed in the registry
- Website
- Not disclosed in the registry
- E-delivery address
- AE:PL-46681-64097-BFRHW-07
Risk and payment profile - Leaderna Platform
Credibility rating
41.8 / 100
Average credibility
Insolvency risk
Low
Elevated threat
Closure risk
41
/ 100
Risk comparison - scale 0 (safe) → 100 (critical)
Organizational stability signals
No instability signals - ownership, management, PKD codes and company name remain relatively stable.
Shareholder changes
2
2/6 yrs
Board changes
1
1/6 yrs
PKD changes
1
1/6 yrs
Name changes
0
0/6 yrs
Data from 6 years of registry activity.
Credibility history
Payment reliability score from 2020–2024
Current: D (42/100)
Trend: stable (-1.6 pts/year)
Słaba wiarygodność płatnicza – wskaźniki finansowe sugerują podwyższone ryzyko opóźnień lub niewykonania zobowiązań.
Trade credit limit history
Standard limit from 2020–2024
Current: 13.3 K PLN
Safe: 4.0 K PLN
Difference between risk models
Closure - probability of ceasing operations (operational continuity). Insolvency - probability of formal bankruptcy / restructuring. The models use different data - results can diverge significantly when balance-sheet data is incomplete.
Operational status - Leaderna Platform
Founded
July 2, 2020
5 years in operation
Legal form
SPÓŁKA Z OGRANICZONĄ ODPOWIEDZIALNOŚCIĄ
Registry: RejP
Headquarters
GDAŃSK
POMORSKIE
Primary PKD
72.10.Z
Scientific research and development
Share capital
66.1 K PLN
1,256 shares total
Shareholders
5
shareholders
Board
2 people
Filed years
5 years
2020–2024 · profitable: 1/5
Registry entries
26
latest: June 26, 2026
Risk signals
Revenue
0 PLN
2024
Net profit
-36.6 K PLN
2024
Assets
509.8 K PLN
2024
Equity
314.4 K PLN
2024
EBITDA
-24.3 K PLN
2024
Valuation
114.5 K PLN
Low confidence
Low confidence
Companies in the same location
Public procurement
Trademarks
Reviews
Rate business credibility - Leaderna Platform.
No ratings
Related articles
News
Bioceltix in the final EMA dialogue phase: BCX-CM-J could become Europe's first veterinary cell-therapy drug for dogs
Wrocław-based Bioceltix S.A. (KRS 0000744521) entered Q2 2026 in the final EMA dialogue phase regarding BCX-CM-J - Europe's first veterinary cell-therapy drug from mesenchymal stem cells for dogs with osteoarthritis. Responses to the final EMA questions are due in May 2026; the CVMP recommendation and marketing authorisation are possible in Q3/Q4 2026. Pre-commercial biotech: 2024 closed with a PLN 14.9 m loss on zero revenue; cash of PLN 33.6 m at year-end. Trigon DM maintained a buy rating with a price target of PLN 127.2.
News
Captor Therapeutics: PLN 36 m of cash at 30 September 2025, runway to mid-2026 - clinical data versus the cash clock
Wrocław-based Captor Therapeutics S.A. (KRS 0000756383) - a pre-commercial biotech specialising in TPD (Targeted Protein Degradation) - closed Q3 2025 with PLN 36 m of cash and grants securing financing to mid-2026. CT-01 (hepatocellular carcinoma) entered Phase I - the first patient dosed at Barcelona Clinic Liver Cancer. CT-03 (MCL-1 degrader) nearing clinical entry. Without a new R&D partnership or equity issuance in 2026, the company will need additional financing.
